SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
43 hedge funds and large institutions have $1.2M invested in Syros Pharmaceuticals, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 29 closing their positions.
Holders
43
Holders Change
-21
Holders Change %
-32.81%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
9
Reduced
7
Closed
29
Calls
$55K
Puts
$355K
Net Calls
-$300K
Net Calls Change
+$2.15M
Top Buyers
| 1 |
1
Acadian Asset Management
Boston,
Massachusetts
|
$55K |
| 2 |
AAA
2
Affinity Asset Advisors
New York
|
$34.5K |
| 3 |
3
Citigroup
New York
|
$32K |
| 4 |
TSS
4
Two Sigma Securities
New York
|
$24.8K |
| 5 |
HF
5
HRT Financial
New York
|
$20K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CFGS
76
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
77
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | – | – |
|